Concepedia

Tomasz Knurowski

TK

Statistics

Publications

5

Citations

179

H-Index

5

Active since

2004

Affiliations

CellCentric (United Kingdom)(Current)

Cancer Research UK Manchester Institute

University of Manchester

Tomasz Knurowski is an author at CellCentric (United Kingdom) specializing in medicine, cancer pharmacology, and oncology.

Publications per year

2004–2023

5

Publications

5

Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies

Luciano Nicosia, Gary J. Spencer, Nigel Brooks et al. · Cancer Cell · 2023 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

Survey of health status and quality of life of the elderly in Poland and Croatia.

Tomasz Knurowski, Jitse P. van Dijk, Andrea Madarasová Gecková et al. · PubMed · 2004 · 28 citations · Full text

Medicine, Geriatric Medicine, Psychiatry +17

An open label phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumors.

Johann S. de Bono, Elena Cojocaru, Elizabeth Ruth Plummer et al. · Journal of Clinical Oncology · 2019 · 16 citations

Medicine, Oncology, Pharmacology +17

CCS1477, a Novel p300/CBP Bromodomain Inhibitor, Enhances Efficacy of Azacitidine and Venetoclax in Pre-Clinical Models of Acute Myeloid Leukaemia and Lymphoma

Nigel Brooks, Tomasz Knurowski, Andrew Hughes et al. · Blood · 2021 · 12 citations

Medicine, Oncology, Pharmacology +15

A Phase I Study Of The Oral Btk Inhibitor ONO-4059 In Patients With Relapsed/Refractory B-Cell Lymphoma

Simon Rule, Nimish Shah, Gilles Salles et al. · Blood · 2013 · 12 citations

Medicine, Oncology, Pharmacotherapy +10

1–5 of 5